Know Cancer

or
forgot password

Liver Transplantation and Metastatic Colo-rectal Cancer.


Phase 2
18 Years
N/A
Open (Enrolling)
Both
Colo-rectal Cancer

Thank you

Trial Information

Liver Transplantation and Metastatic Colo-rectal Cancer.


Survival, time to progression, other malignancy, side-effects, quality of life.


Inclusion Criteria:

Colo-rectal cancer -

Exclusion Criteria:

-

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Survival

Outcome Time Frame:

6 years

Safety Issue:

No

Principal Investigator

Svein Dueland, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Rikshospitalet-Radiumhospitalet RRHF

Authority:

Norway: South region committee for research ethics in Norway

Study ID:

S-05409 (SECA I)

NCT ID:

NCT00294827

Start Date:

February 2006

Completion Date:

May 2020

Related Keywords:

  • Colo-rectal Cancer
  • Liver transplantation
  • Rectal Neoplasms
  • Colorectal Neoplasms

Name

Location